Nuclear or cytoplasmic expression of survivin: What is the significance? von Li, Fengzhi, Yang, Jie, Ramnath, Nithya, Javle, Milind M., Tan, Dongfeng

Volltext

Risk factors associated with earlier age of onset in familial pancreatic carcinoma von James, Ted A., Sheldon, David G., Rajput, Ashwani, Kuvshinoff, Boris W., Javle, Milind M., Nava, Hector R., Smith, Judy L., Gibbs, John F.

Volltext

Should adjuvant therapy remain the standard of care for patients with resected adenocarcinoma of the pancreas? von Chu, Quyen D, Khushalani, Nikhil, Javle, Miland M, Douglass, Jr, Harold O, Gibbs, John F

Volltext

S-phase modulation by irinotecan : pilot studies in advanced solid tumors von RAMNATH, N, KHUSHALANI, N, JAVLE, M. M, BERDZIK, J, CREAVEN, P. J, RUSTUM, Y. M, TOTH, K, LITWIN, A. M, INTENGAN, M. E, SLOCUM, H. K, PENDYALA, L, SMITH, P. F, STEWART, C. C, HOFFMAN, J. L

Volltext

Management of locoregional stage esophageal cancer: a single center experience von Javle, M. M., Nwogu, C. E., Donohue, K. A., Iyer, R. V., Brady, W. E., Khemka, S. V., Smith, J. L., Demmy, T. L., Yang, G. Y., Nava, H. R.

Volltext

Postoperative computed tomography scan surveillance for patients with stage II and III colorectal cancer: worthy of further study? von Mortazavi, Amir, Shaukat, Aasma, Othman, Edress, Kepner, James L, Fakih, Marwan G, Kuvshinoff, Boris W, Smith, Judy L, Javle, Milind M

Volltext

Case 3. Gastric signet ring carcinoma presenting as a diffuse thigh mass von VARMA, Geetha N, WINSTON, Janet S, HILL, Hank C, GIBBS, John F, PROULX, Gary M, MCGRATH, Brian E, JAVLE, Milind M

Volltext

Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy Trial von Zhu, AX, Macarulla, T, Javle, MM, Kelley, RK, Lubner, SJ, Adeva, J, Cleary, JM, Catenacci, DVT, Borad, MJ, Bridgewater, JA, Harris, WP, Murphy, AG, Oh, D-Y, Whisenant, JR, Lowery, MA, Goyal, L, Shroff, RT, El-Khoueiry, AB, Chamberlain, CX, Aguado-Fraile, E, Choe, S, Wu, B, Liu, H, Gliser, C, Pandya, SS, Valle, JW, Abou-Alfa, GK

Volltext bestellen

Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study von Abou-Alfa, GK, Macarulla, T, Javle, MM, Kelley, RK, Lubner, SJ, Adeva, J, Cleary, JM, Catenacci, DV, Borad, MJ, Bridgewater, J, Harris, WP, Murphy, AG, Oh, D-Y, Whisenant, J, Lowery, MA, Goyal, L, Shroff, RT, El-Khoueiry, AB, Fan, B, Wu, B, Chamberlain, CX, Jiang, L, Gliser, C, Pandya, SS, Valle, JW, Zhu, AX

Volltext bestellen